Premenstrual dysphoric disorder (PMDD) is not caused by abnormal hormone levels. Women with PMDD have the same concentrations of estrogen and progesterone as women without it. Instead, PMDD is caused by an abnormal cellular response to normal hormonal fluctuations during the menstrual cycle, affecting roughly 3% to 8% of people who menstruate. The root of the problem lies in how the brain and body process those hormones, not how much of them are present.
An Abnormal Brain Response to Normal Hormones
Every menstrual cycle, progesterone rises sharply after ovulation and falls before menstruation begins. Your body converts some of that progesterone into a compound called allopregnanolone, which normally has a calming effect. It works by enhancing the activity of the brain’s main inhibitory signaling system, the same system targeted by anti-anxiety medications and alcohol. In most people, rising allopregnanolone during the second half of the cycle promotes a sense of calm and emotional stability.
In people with PMDD, the brain’s receptors for this calming signal don’t respond the way they should. Instead of adapting smoothly to the rise and fall of allopregnanolone, they react poorly, sometimes paradoxically. This impaired receptor response leads to mood instability, irritability, anxiety, and difficulty handling stress. Research from multiple labs describes PMDD as a disorder of suboptimal sensitivity to these hormone-derived brain chemicals, with the core problem being the brain’s failure to adjust to their natural fluctuations across the cycle.
Serotonin Changes in the Luteal Phase
The serotonin system also behaves differently in PMDD. Brain imaging studies using PET scans have found that key serotonin receptors in the brainstem change their activity between the first and second halves of the menstrual cycle in healthy women. In women with PMDD, this shift is significantly smaller. The receptors essentially stay flatter across the cycle when they should be adjusting.
This blunted serotonin response helps explain why SSRIs (a class of antidepressant that increases serotonin availability) are one of the most effective treatments for PMDD. Notably, SSRIs work faster for PMDD than for depression. In depression, these medications typically take weeks to show results. In PMDD, many people feel improvement within days. Antidepressants that target other brain chemicals besides serotonin don’t help PMDD at all, which suggests the serotonin system plays a uniquely important role in the condition, separate from its role in depression.
A Genetic Component in Cell Behavior
Research at Johns Hopkins identified a group of genes, collectively called the ESC/E(Z) complex, that behave differently in women with PMDD. This gene complex helps regulate how cells respond to estrogen and progesterone. In cells from women with PMDD, these genes showed a distinct pattern: their messenger RNA (the instructions cells use to build proteins) was overexpressed, but the actual proteins those instructions were supposed to produce were underexpressed. The cells were, in a sense, getting louder instructions but producing a weaker response.
Even more telling, when researchers exposed these cells to progesterone, cells from healthy women showed increased activity in these genes, while cells from women with PMDD did not respond the same way. Estrogen actually decreased the expression of these genes in PMDD cells. This is strong evidence that PMDD has a biological, heritable basis at the cellular level. It’s not a matter of emotional sensitivity or stress tolerance. The cells themselves process reproductive hormones differently.
Why Symptoms Follow a Cyclical Pattern
PMDD symptoms appear during the luteal phase, the roughly two weeks between ovulation and the start of your period. This is when progesterone and its brain-active byproducts peak and then drop. Symptoms typically begin several days before menstruation, start improving within a few days of bleeding, and resolve almost completely within about a week after your period starts. This strict timing is one of the key features that separates PMDD from other mood disorders.
The cyclical pattern makes sense given the underlying biology. The brain’s impaired response to allopregnanolone and blunted serotonin receptor adjustments only become a problem when hormone levels are actively shifting. During the first half of the cycle, when progesterone is low and stable, the faulty signaling system isn’t being challenged, and symptoms stay quiet.
PMDD vs. Premenstrual Exacerbation
Not every severe premenstrual mood change is PMDD. A related but distinct pattern called premenstrual exacerbation (PME) occurs when someone with an existing condition, like depression or generalized anxiety, finds their baseline symptoms get noticeably worse before their period. The difference is timing and resolution. With PMDD, symptoms appear only during the luteal phase and fully resolve after menstruation. With PME, symptoms are present throughout the month but intensify premenstrually, and they don’t fully disappear after bleeding starts.
PME doesn’t introduce new symptoms. It amplifies whatever is already there. Someone with ongoing depression who experiences deeper sadness and more fatigue before their period likely has PME, not PMDD. Distinguishing between the two requires tracking symptoms daily for at least two full menstrual cycles, noting whether they’re exclusive to the premenstrual window or present all month with a premenstrual spike. This distinction matters because the underlying causes and treatment approaches differ.
What This Means for Treatment
Because PMDD stems from how the brain processes normal hormonal changes rather than from excess or deficient hormones, treatment targets those processing pathways. SSRIs work by compensating for the blunted serotonin response, and they can be taken either daily or only during the luteal phase. Hormonal approaches aim to suppress ovulation entirely, eliminating the hormonal fluctuations that trigger the abnormal brain response. Both strategies address the root mechanism: not the hormones themselves, but the body’s reaction to them.
Understanding the cause also clarifies what PMDD is not. It is not a psychological weakness, a stress response, or an exaggerated version of typical PMS. It is a genetically influenced condition in which cells and brain receptors respond abnormally to routine reproductive hormone cycles. That biological distinction has been confirmed at the genetic, cellular, and neuroimaging levels.